Obesity in primary antiphospholipid syndrome is associated with worse outcome

Joint Bone Spine

Volumn 78, Issue 3, 2011, Pages 324-325

  Caldas, Cezar A ^a   da Mota, Licia Maria Henrique ^b   de Carvalho, Jozélio Freire ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

Antiphospholipid syndrome; Body mass index; Obesity; Thrombosis

Indexed keywords

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; BODY WEIGHT; CLINICAL ARTICLE; FEMALE; HUMAN; LETTER; MALE; OBESITY; OUTCOME ASSESSMENT; SPONTANEOUS ABORTION; THROMBOCYTOPENIA; VEIN THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BODY MASS INDEX; BRAZIL; COMORBIDITY; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PULMONARY EMBOLISM;

EID: 79955543065     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2010.12.003     Document Type: Letter

References (10)

1. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunological manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002, 46:1019-1027.
2. Eichinger S., Hron G., Bialonczyk C., et al. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med 2008, 168:1678-1683.
3. Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004, 103:219-224.
4. Medina G., Casaos D., Jara L.J., et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003, 62:607-610.
5. Wilson W.A., Gharavi A.E., Koike T., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
6. Pierangeli S.S., Harris E.N. A protocol for determination of anticardiolipin antibodies by ELISA. Nat Protoc 2008, 3:840-848.
7. Wisløff F., Jacobsen E.M., Liestøl S. Laboratory diagnosis of the antiphospholipid syndrome. Thromb Res 2002, 108:263-271.
8. Borba E.F., Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus 1997, 6:533-539.
9. González D.A., De León A.C., Rodríguez Pérez M.C., et al. Inverse association between obesity and antinuclear antibodies in women. J Rheumatol 2008, 35:2449-2451.
10. Brito Diáz B., Rodriguez Pérez M.C., Cabrera de León A. The vicious circle of leptin and obesity. Curr Nutr Food Sci 2006, 2:361-373.